Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Medical Bud News.
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role
GlobeNewswire, Inc.
·
April 24, 2025
Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected in the...
Doc Beverly Potter Launches Books on Health and Natural Wellness at London Book Fair 2025
EIN Presswire
·
March 8, 2025
Explore the healing potential of “Cannabis for Seniors” and discover the magic of “Terpenes.” COOKSTOWN, NJ, UNITED STATES, March 8, 2025 /EINPresswire.com/ -- Author Doc Beverly Potter dives deep into the world of cannabis and its therapeutic...
Best THC Detox by HeadShop: Most Effective THC Detox Kits, Drinks & Cleansing Methods
GlobeNewswire, Inc.
·
April 18, 2025
New York City, April 17, 2025 (GLOBE NEWSWIRE) -- Introduction – The Rising Demand for Fast, Reliable THC Detox Solutions Over the past few years, cannabis use has become more socially accepted and legally permitted across many states. But one...
Buscar Company Acquires 70% Stake in Armorgenix
EIN Presswire
·
June 2, 2025
Buscar Company (OTCMKTS:CGLD) BEVERLY HILLS, CA, CA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S....
Earth Buddy Launches 'Chill the F Out!' Campaign to Help Dogs Cope with Summer Stress
EIN Presswire
·
June 5, 2025
As summer kicks off, Earth Buddy is helping pet parents prepare for a season that can be especially stressful for dogs. LONGMONT, CO, UNITED STATES, June 5, 2025 /EINPresswire.com/ -- As summer kicks off, Earth Buddy is helping pet parents...
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
GlobeNewswire, Inc.
·
June 10, 2025
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic...
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s Biotechnology Regulations
GlobeNewswire, Inc.
·
June 6, 2025
SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies, announced today that its most recent trait for its...
Revive Therapeutics Advances with Next-Generation Bucillamine Development
GlobeNewswire, Inc.
·
June 4, 2025
TORONTO, June 04, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical...
RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties
GlobeNewswire, Inc.
·
February 10, 2025
Glen Rock, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of...
Epilepsy Foundation of America Awards $250,000 at 13th Annual Shark Tank Competition
GlobeNewswire, Inc.
·
June 3, 2025
Janine Erler, winner of the 2025 Investment Prize for Neumirna Therapeutics. Presenting the prize is Bernice Martin Lee, Epilepsy Foundation of America’s (EFA) Chief Executive Officer; Jacqueline French, MD, EFA’s Medical Director; and Caitlin...
Revive Therapeutics Announces Proposed Shares for Debt Transaction
GlobeNewswire, Inc.
·
April 21, 2025
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious...
Visionaries, Healers, and Activists to Explore the Intersection of Psychedelics and Society at Psychedelic Science 2025
GlobeNewswire, Inc.
·
June 3, 2025
• Sessions span grassroots health interventions, traditional practices, psychedelic parenting education, journalism, ecological health, raves and music, leadership transformation, and more • Speakers include faith leaders, journalists, community...
Texas Conducts Week-Long Operation To Disrupt Terrorist Cartel Activity
Office of the Texas Governor
·
June 6, 2025
TEXAS, June 6 - June 6, 2025 | Austin, Texas | Press Release Governor Greg Abbott, the Texas Department of Public Safety (DPS), and the Texas National Guard continue to work together with the Trump Administration to secure the border; stop the...
Beast Force for Men Examined: The Best Blood Flow Booster on the Market (Elephant Root Trick)
GlobeNewswire, Inc.
·
April 8, 2025
New York City, April 08, 2025 (GLOBE NEWSWIRE) -- Are you struggling to keep up in the bedroom, losing confidence, or feeling like your stamina just isn't what it used to be? You're not alone. But there's hope. Beast Force for Men, a breakthrough...
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
GlobeNewswire, Inc.
·
June 4, 2025
NEWARK, N.J., June 04, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today the final results and closing of its $25.0 million rights offering (the “Rights Offering”). The subscription period of the...
Drug Screening Market CAGR 12.29 % with Growth USD 16814.2 Billion by 2033
EIN Presswire
·
June 3, 2025
Drug Screening market size is anticipated to be worth USD 6651.93 million in 2025 and is expected to reach 16814.2 million by 2033 at a CAGR of 12.29%. PUNE, INTERNATIONAL, INDIA, June 3, 2025 /EINPresswire.com/ -- "Drug Screening Market"...
Avicanna To Hold Full Year 2024 Earnings Conference Call
GlobeNewswire, Inc.
·
March 18, 2025
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived...
Truvarin Under Review: Enriched Hair Regrowth Spray Supplement for Bald Spots in Men & Women
GlobeNewswire, Inc.
·
May 10, 2025
New York, May 10, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The emotional and psychological toll of hair loss in men and women, and how it impacts self-esteem and confidence The underlying causes of hair thinning and bald spots,...
iAnthus Expands Presence in Florida with New GrowHealthy Dispensary in Jacksonville
GlobeNewswire, Inc.
·
February 26, 2025
NEW YORK and TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, has...
MariMed’s Premium Nature’s Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose
GlobeNewswire, Inc.
·
May 29, 2025
NORWOOD, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), the company behind the award-winning flower and concentrate brand, Nature’s Heritage™, continued to drive innovation with the launch of MycroDose...